Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
1994-1-6
pubmed:abstractText
A convenient synthesis of 5-fluoro-2-thiouracil (11) is based on hydrolytic deamination of 5-fluoro-2-thiocytosine (9). Lewis acid-catalyzed condensation of di-TMS-5-fluoro-2-thiouracil (13) or di-TMS-2-thiouracil (14) with 2-deoxy-3,5-di-O-p-toluyl-D-ribofuranosyl chloride (15) led to mixtures of the beta- and alpha-anomers of 3',5'-toluylated 2'-deoxy-5-fluoro-2-thiouridine (16 and 18) or 2'-deoxy-2-thiouridine (17 and 19), each of which was deblocked with MeOH-NH3 to give the desired free anomeric nucleoside pairs 1, 5 and 3, 7, respectively. These were selectively converted to the corresponding 5'-monophosphates 2, 6 and 4, 8, with the aid of the wheat shoot phosphotransferase system. Conformations of the nucleosides 1, 3, 5, 7 are deduced from 1H NMR spectra, and circular dichroism spectra for nucleotide anomeric pairs 2, 6 and 4, 8 are reported. Whereas beta-2-thio-dUMP (4) was a good substrate (Km approximately 10(-5) M), beta-5-fluoro-2-thio-dUMP (2) proved to be a potent competitive, slow-binding inhibitor (Ki approximately 10(-8) M) of the purified enzymes from Ehrlich ascites carcinoma and L1210 cells. The alpha-anomer 6 was a weak inhibitor, with Ki in the mM range, and its congener 8 hardly interacted with the enzyme. The beta-anomer 1 exhibited antitumor activity in a mouse leukemic cell line L5178Y (IC50 approximately 10(-6) M), hence 40-100-fold weaker than 5-fluoro-dUrd. Its alpha-anomer 5 was 10-fold less active, but exhibited at least 10-fold higher selectivity with respect to the tumor cells than the beta-anomer 1.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3611-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8246229-3T3 Cells, pubmed-meshheading:8246229-Animals, pubmed-meshheading:8246229-Antineoplastic Agents, pubmed-meshheading:8246229-Binding, Competitive, pubmed-meshheading:8246229-Carcinoma, Ehrlich Tumor, pubmed-meshheading:8246229-Cell Division, pubmed-meshheading:8246229-Deoxyuracil Nucleotides, pubmed-meshheading:8246229-Drug Screening Assays, Antitumor, pubmed-meshheading:8246229-Floxuridine, pubmed-meshheading:8246229-Kinetics, pubmed-meshheading:8246229-Leukemia L1210, pubmed-meshheading:8246229-Mice, pubmed-meshheading:8246229-Spectrophotometry, pubmed-meshheading:8246229-Stereoisomerism, pubmed-meshheading:8246229-Structure-Activity Relationship, pubmed-meshheading:8246229-Thiouridine, pubmed-meshheading:8246229-Thymidylate Synthase, pubmed-meshheading:8246229-Tumor Cells, Cultured
pubmed:year
1993
pubmed:articleTitle
2-Thio derivatives of dUrd and 5-fluoro-dUrd and their 5'-monophosphates: synthesis, interaction with tumor thymidylate synthase, and in vitro antitumor activity.
pubmed:affiliation
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warszawa.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't